Neurons that produce dopamine are degraded in Parkinson’s disease. Although replacing dopamine can improve the resulting loss of motor function, such treatments can also produce involuntary movements, or dyskinesia.
Scientists in the journal PNAS investigated the molecular pathways that lead to this dyskinesia in an effort to ameliorate the condition. Because upregulating serotonin can reduce dyskinesia, the authors focused on p11, a cellular scaffold protein that increases the presence of certain serotonin receptors in the brain.
Using mice with brain lesions similar to those found in Parkinson’s disease, the authors injected small viral vectors encoding an RNA molecule that blocks p11 production in the dorsal striatum, a brain region that responds to dopamine.
Despite predictions that blocking p11 would worsen dyskinesia, the treatment improved motor function. When the mice were treated with dopamine, they showed reduced indicators of dyskinesia.
Because p11 is found throughout the brain, the authors note that systemic p11 blockade could produce side effects such as depression, but suggest that blocking p11 in the dorsal striatum alone may offer a potentially viable therapeutic strategy for Parkinson’s disease.
http://www.pnas.org/content/early/2016/01/13/1524387113
Edited
Latest News
Abusive drugs hijack natura…
By newseditor
Posted 23 Apr
Mechanism of action of the…
By newseditor
Posted 23 Apr
Role of fat in rare neurolo…
By newseditor
Posted 23 Apr
How protein synthesis in de…
By newseditor
Posted 22 Apr
Atlas of mRNA variants in d…
By newseditor
Posted 22 Apr
Other Top Stories
Epigenetic mechanisms control HIV susceptibility
Read more
Inflammation and microRNA connection to muscular dystrophy
Read more
A distinct function of regulatory T cells in tissue protection
Read more
Novel role of mitochondria in immune function
Read more
Sugar governs how antibodies work in the immune system
Read more
Protocols
A programmable targeted pro…
By newseditor
Posted 23 Apr
MemPrep, a new technology f…
By newseditor
Posted 08 Apr
A tangible method to assess…
By newseditor
Posted 08 Apr
Stem cell-derived vessels-o…
By newseditor
Posted 06 Apr
Single-cell biclustering fo…
By newseditor
Posted 01 Apr
Publications
Exploiting pancreatic cance…
By newseditor
Posted 23 Apr
Structure of antiviral drug…
By newseditor
Posted 23 Apr
Type-I-interferon-responsiv…
By newseditor
Posted 23 Apr
Selenium, diabetes, and the…
By newseditor
Posted 23 Apr
Long-term neuropsychologica…
By newseditor
Posted 23 Apr
Presentations
Hydrogels in Drug Delivery
By newseditor
Posted 12 Apr
Lipids
By newseditor
Posted 31 Dec
Cell biology of carbohydrat…
By newseditor
Posted 29 Nov
RNA interference (RNAi)
By newseditor
Posted 23 Oct
RNA structure and functions
By newseditor
Posted 19 Oct
Posters
A chemical biology/modular…
By newseditor
Posted 22 Aug
Single-molecule covalent ma…
By newseditor
Posted 04 Jul
ASCO-2020-HEALTH SERVICES R…
By newseditor
Posted 23 Mar
ASCO-2020-HEAD AND NECK CANCER
By newseditor
Posted 23 Mar
ASCO-2020-GENITOURINARY CAN…
By newseditor
Posted 23 Mar